Kyrgyz president rules to hold WWII victory parade on May 9
RVSN not to launch Dnepr missile from Yasny launch base in 2015
Ukrainian police begin arrests of miners protesting in capital
France’s return of €1.5-bln prepayment for Mistrals acceptable fo Russia — source
Russia urges Ukrainian authorities to stop illegal checks of OSCE monitors
Leader of gang operating in Dagestan liquidatedRussia April 27, 11:52
Kyrgyz president rules to hold WWII victory parade on May 9World April 27, 11:34
Ukraine’s Rada speaker signs recommendation to impose sanctions against Russian presidentWorld April 27, 10:52
RVSN not to launch Dnepr missile from Yasny launch base in 2015Russia April 27, 10:45
Russia expects confirmation of NPT viability — foreign ministryWorld April 27, 10:28
Putin congratulates Nazarbayev on Kazakhstan presidential election victoryWorld April 27, 9:59
Russia urges Ukrainian authorities to stop illegal checks of OSCE monitorsWorld April 27, 9:52
Wildfire-hit area in Russia’s Siberia continues to growRussia April 27, 9:28
Death toll in Nepal earthquake climbs to over 3,200World April 27, 8:55
NOVOSIBIRSK, October 30 (Itar-Tass) - Scientists of the Institute of Clinical Immunology in the Siberian branch of the Russian Academy of Medical Sciences in Novosibirsk have developed a vaccine for the treatment of cancer, the institute's director, Professor Vladimir Kozlov, told Itar-Tass on Wednesday.
The vaccine has already successfully passed clinical tests. Currently, it is being given to patients by injection at the third and fourth stages of cancer and is reported as having increased patient lifespan more than twofold.
“We are deriving dendritic cells from the human body and loading them with tumor antigens," the scientist said. "Dendritic cells process them, then we inject the cells into the patient and they start working in the body evoking a strong immune response. That is, they are actively fighting the tumor."
The institute's creation "is not a classical vaccine, which is the means to prevent the illness", Professor Kozlov said. "In fact, it is cell therapy.”
The vaccine is counteracting several types of cancer - colorectal (bowel) cancer, breast cancer and prostate cancer - and the institute is ready to start its industrial production, Kozlov added.
He warned, however, that “one should not seek a panacea for malign tumors as they cannot be overcome with only one tool. Along with dendritic cells, there are other cells that fight cancer so all means are to be applied in complex. An immunomodulating cocktail is needed for a far-reaching effect,” Kozlov said.
Other types of therapy were to be used as well, such as chemotherapy and radiation therapy, the professor said. Treatment should vary case by case, he said, adding that the institute was already developing preventive vaccines against other illnesses, atherosclerosis among them, and that they would be presented soon.